TY - JOUR
T1 - Cytotoxicity enhancement of doxorubicin in conjugation with PAMAM G4.5 dendrimer containing gold nanoparticles
AU - Sagita, Erny
AU - Djajadisastra, Joshita
AU - Mutalib, Abdul
N1 - Publisher Copyright:
© 2016, Sphinx Knowledge House. All rights reserved.
PY - 2016
Y1 - 2016
N2 - Poly(amidoamine) dendrimer (PAMAM) encapsulated gold nanoparticles (AuNPs) were prepared by reduction of gold salts with NaBH4. The dendrimers used were PAMAM generation 4. 5 having carboxyl groups surface. After incorporation of AuNPs into PAMAM, doxorubicin molecules were attached to PAMAM surface groups via ester linkage using dicyclohexylcarbodiimide coupling reaction. The conjugates obtained were characterized by UV-Vis spectroscopy, infrared spectroscopy, dynamic light scattering and transmission electron microscopy. We also evaluated cytotoxicity of doxorubicin before and after conjugation with PAMAM-AuNPs. As the result, we could prepare conjugate of doxorubicin-PAMAM-AuNPs (DOX-PAMAM-AuNPs) with particle size of 25. 92 ± 7. 99 nm (using TEM) and 147. 88 nm (using DLS method). From this research, we found that DOX-PAMAM-AuNPs conjugate could reduce doxorubicin binding to human serum albumin, from 60. 71 ± 0. 99% to 47. 12 ± 12. 39%. Cytotoxicity assay of DOX-PAMAM-AuNPs conjugate against MCF-7 cell line gave IC50 value at 0. 035 ± 0. 039 μg/mL, while free doxorubicin had larger IC50 value, which was0. 868 ± 0. 235 μg/mL.
AB - Poly(amidoamine) dendrimer (PAMAM) encapsulated gold nanoparticles (AuNPs) were prepared by reduction of gold salts with NaBH4. The dendrimers used were PAMAM generation 4. 5 having carboxyl groups surface. After incorporation of AuNPs into PAMAM, doxorubicin molecules were attached to PAMAM surface groups via ester linkage using dicyclohexylcarbodiimide coupling reaction. The conjugates obtained were characterized by UV-Vis spectroscopy, infrared spectroscopy, dynamic light scattering and transmission electron microscopy. We also evaluated cytotoxicity of doxorubicin before and after conjugation with PAMAM-AuNPs. As the result, we could prepare conjugate of doxorubicin-PAMAM-AuNPs (DOX-PAMAM-AuNPs) with particle size of 25. 92 ± 7. 99 nm (using TEM) and 147. 88 nm (using DLS method). From this research, we found that DOX-PAMAM-AuNPs conjugate could reduce doxorubicin binding to human serum albumin, from 60. 71 ± 0. 99% to 47. 12 ± 12. 39%. Cytotoxicity assay of DOX-PAMAM-AuNPs conjugate against MCF-7 cell line gave IC50 value at 0. 035 ± 0. 039 μg/mL, while free doxorubicin had larger IC50 value, which was0. 868 ± 0. 235 μg/mL.
KW - Doxorubicin
KW - Gold Nanoparticles
KW - PAMAM G4. 5 Dendrimer
UR - http://www.scopus.com/inward/record.url?scp=84982270072&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84982270072
SN - 0974-4304
VL - 9
SP - 347
EP - 356
JO - International Journal of PharmTech Research
JF - International Journal of PharmTech Research
IS - 6
ER -